The Central Epidemic Command Center (CECC) yesterday said that Taiwan has secured nearly 15 million COVID-19 vaccine doses, and a purchase of 5 million more is being negotiated, but the earliest delivery would be in March.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the CECC, said that the figure includes 4.76 million doses from the COVAX global distribution program, and 10 million doses from the University of Oxford and AstraZeneca PLC.
Negotiations to purchase about 5 million doses from another drug company are ongoing, he said.
Photo: EPA
The cold-chain system for transporting and storing vaccines has been prepared for March, Chen said, adding that the center is also approaching vaccine companies that have entered phase 3 clinical trials.
For risk diversification and securing safe and effective vaccines as early as possible, the CECC has taken multiple approaches to securing COVID-19 vaccines, including “international investment” such as joining the COVAX platform, “direct purchases from vaccine manufacturers” and “investment in domestic vaccine makers,” he said.
Domestic vaccine maker Adimmune Corp (國光生技) cannot decide on the optimal dose for its candidate after its phase 1 clinical trials, so the center has suggested it reconduct dose-ranging, the minister said.
He said that Medigen Vaccine Biologics Corp (高端疫苗) has gained conditional approval to enter phase 2 clinical trials, and United Biomedical Inc (聯亞生技) is expected to provide all of the data from its phase 1 clinical trials for review next month.
The center plans to secure vaccines for at least 65 percent of the population to achieve effective herd immunity, so as each person would need two jabs, the aim is to obtain approximately 30 million doses of COVID-19 vaccines, Chen said.
The CECC announced nine priority groups for COVID-19 vaccines, once they become available.
The first priority group would be healthcare professionals, followed by central and local government disease prevention personnel, including airport personnel who might come into close contact with infected individuals, and police and military police.
After that, care facility workers, home care providers and social workers — including domestic migrant workers — would be prioritized, followed by military personnel and people aged 65 or older.
The last three priority groups are people aged 19 to 64 with high-risk diseases, followed by people with a rare disease or catastrophic illness, and adults aged 50 to 64.
When the vaccines become available in Taiwan, people in the priority groups can choose whether they want to get vaccinated, but they would not be able to choose the brand of vaccine, Chen said.
It would be difficult to predict how long it would take for the 20 million COVID-19 vaccine doses to be administered, but it could take up to a year, Chen said.
Taiwanese actress Barbie Hsu (徐熙媛) has died of pneumonia at the age of 48 while on a trip to Japan, where she contracted influenza during the Lunar New Year holiday, her sister confirmed today through an agent. "Our whole family came to Japan for a trip, and my dearest and most kindhearted sister Barbie Hsu died of influenza-induced pneumonia and unfortunately left us," Hsu's sister and talk show hostess Dee Hsu (徐熙娣) said. "I was grateful to be her sister in this life and that we got to care for and spend time with each other. I will always be grateful to
REMINDER: Of the 6.78 million doses of flu vaccine Taiwan purchased for this flu season, about 200,000 are still available, an official said, following Big S’ death As news broke of the death of Taiwanese actress and singer Barbie Hsu (徐熙媛), also known as Big S (大S), from severe flu complications, the Centers for Disease Control (CDC) and doctors yesterday urged people at high risk to get vaccinated and be alert to signs of severe illness. Hsu’s family yesterday confirmed that the actress died on a family holiday in Japan due to pneumonia during the Lunar New Year holiday. CDC Deputy Director-General Tseng Shu-hui (曾淑慧) told an impromptu news conference that hospital visits for flu-like illnesses from Jan. 19 to Jan. 25 reached 162,352 — the highest
TAIWAN DEFENSE: The initiative would involve integrating various systems in a fast-paced manner through the use of common software to obstruct a Chinese invasion The first tranche of the US Navy’s “Replicator” initiative aimed at obstructing a Chinese invasion of Taiwan would be ready by August, a US Naval Institute (USNI) News report on Tuesday said. The initiative is part of a larger defense strategy for Taiwan, and would involve launching thousands of uncrewed submarines, surface vessels and aerial vehicles around Taiwan to buy the nation and its partners time to assemble a response. The plan was first made public by the Washington Post in June last year, when it cited comments by US Indo-Pacific Commander Admiral Samuel Paparo on the sidelines of the Shangri-La Dialogue
COMBINING FORCES: The 66th Marine Brigade would support the 202nd Military Police Command in its defense of Taipei against ‘decapitation strikes,’ a source said The Marine Corps has deployed more than 100 soldiers and officers of the 66th Marine Brigade to Taipei International Airport (Songshan airport) as part of an effort to bolster defenses around the capital, a source with knowledge of the matter said yesterday. Two weeks ago, a military source said that the Ministry of National Defense ordered the Marine Corps to increase soldier deployments in the Taipei area. The 66th Marine Brigade has been tasked with protecting key areas in Taipei, with the 202nd Military Police Command also continuing to defend the capital. That came after a 2017 decision by the ministry to station